Karl Bjørnar A.
- Country
- Norway
- Department
- Dept. of Neurology
Research Overview
- Efficacy of Botulinum Toxin Type A in Sphenopalatine Ganglion Blockade for Treatment-Refractory Chronic Migraine: A Randomized Controlled Trial
- A Multicenter Non-Inferiority Trial Comparing Rituximab and Ocrelizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis Aged 18-60 Years
- A phase 3 randomized, placebo-controlled, triple blind parallel-group study of candesartan in adults with episodic cluster headache (Episodic CandClus2)
Data & Insights
Has run more than one trial at 9 of 14 partner sites.
Specializations
Neurological Disorders
This investigator specializes in treating complex neurological conditions, with particular emphasis on multiple sclerosis and chronic migraine management.
- Multiple Sclerosis Treatment Innovation
- Migraine Intervention Techniques
- Neuroimmunological Disorders
The investigator focuses on advanced therapeutic approaches for managing neurological conditions, including targeted biological therapies and innovative intervention methods.
Treatment Modalities
Expertise in implementing various therapeutic interventions, including botulinum toxin treatments and biological therapy applications for neurological conditions.
- Targeted Biological Therapies
- Image-guided Interventions
- Treatment-resistant Conditions
The investigator employs advanced medical technologies and precision-based therapeutic approaches for complex neurological cases.
Clinical Expertise
Specialized in managing treatment-refractory conditions and implementing comparative therapeutic strategies for neurological disorders.
- Comparative Treatment Analyses
- Refractory Disease Management
- Advanced Therapeutic Applications
The investigator focuses on developing and implementing innovative treatment protocols for challenging neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.